Sponsored Symposia: AlloSure dd-cfDNA: RCV and the Value of Longitudinal Surveillance Sponsored by CareDx
March 31, 2021 01:00pm EDT
Originally presented at the AST Cutting Edge of Transplantation (CEoT) Meeting in February 2021, this rebroadcasted session will cover:
- AlloSure reference change value
- Newest AlloSure data from the ADMIRAL Study showing utility of AlloSure in both for cause and surveillance settings
- Value of remote monitoring with AlloSure during COVID
- Patient cases highlighting the value of reference change value in patient surveillance
This is not an official function of the CEoT Meeting and is not endorsed by the AST.
Video will be posted on the AST's Youtube Channel, be sure to subscribe to watch at your convenience.